{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T11:46:10Z","timestamp":1756813570665,"version":"3.44.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,2]]},"DOI":"10.7759\/cureus.91464","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T11:06:03Z","timestamp":1756811163000},"source":"Crossref","is-referenced-by-count":0,"title":["Immune Checkpoint Inhibitor-Induced Subacute Myocarditis"],"prefix":"10.7759","author":[{"given":"Taysir","family":"Al Janabi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohaib","family":"Roomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhinav","family":"Hoskote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.062551","article-title":"Expansion of pathogenic cardiac macrophages in immune checkpoint inhibitor myocarditis","volume":"149","author":"Ma P","year":"2024","unstructured":"Ma P, Liu J, Qin J, et al.. Expansion of pathogenic cardiac macrophages in immune checkpoint inhibitor myocarditis. Circulation. 2024, 149:48-66. 10.1161\/CIRCULATIONAHA.122.062551","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2022.02.002","article-title":"Rheumatic complications of immune checkpoint inhibitors","volume":"48","author":"Ghosh N","year":"2022","unstructured":"Ghosh N, Bass AR. Rheumatic complications of immune checkpoint inhibitors. Rheum Dis Clin North Am. 2022, 48:411-28. 10.1016\/j.rdc.2022.02.002","journal-title":"Rheum Dis Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13071243","article-title":"Immune checkpoint inhibitors-related myocarditis: a review of reported clinical cases","volume":"13","author":"Zotova L","year":"2023","unstructured":"Zotova L. Immune checkpoint inhibitors-related myocarditis: a review of reported clinical cases. Diagnostics (Basel). 2023, 13:10.3390\/diagnostics13071243","journal-title":"Diagnostics (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.02.037","article-title":"Myocarditis in patients treated with immune checkpoint inhibitors","volume":"71","author":"Mahmood SS","year":"2018","unstructured":"Mahmood SS, Fradley MG, Cohen JV, et al.. Myocarditis in patients treated with immune checkpoint inhibitors. J Am Coll Cardiol. 2018, 71:1755-64. 10.1016\/j.jacc.2018.02.037","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056730","article-title":"Identification of pathogenic immune cell subsets associated with checkpoint inhibitor-induced myocarditis","volume":"146","author":"Zhu H","year":"2022","unstructured":"Zhu H, Galdos FX, Lee D, et al.. Identification of pathogenic immune cell subsets associated with checkpoint inhibitor-induced myocarditis. Circulation. 2022, 146:316-35. 10.1161\/CIRCULATIONAHA.121.056730","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2023.2254218","article-title":"Immune checkpoint inhibitor-related myocarditis: current understanding and potential diagnostic and therapeutic strategies","volume":"22","author":"Turker I","year":"2023","unstructured":"Turker I, Johnson DB. Immune checkpoint inhibitor-related myocarditis: current understanding and potential diagnostic and therapeutic strategies. Expert Opin Drug Saf. 2023, 22:909-19. 10.1080\/14740338.2023.2254218","journal-title":"Expert Opin Drug Saf"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.3923","article-title":"Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"4","author":"Wang DY","year":"2018","unstructured":"Wang DY, Salem JE, Cohen JV, et al.. Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis. JAMA Oncol. 2018, 4:1721-8. 10.1001\/jamaoncol.2018.3923","journal-title":"JAMA Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000261","article-title":"Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors","volume":"8","author":"Dolladille C","year":"2020","unstructured":"Dolladille C, Ederhy S, Allouche S, et al.. Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors. J Immunother Cancer. 2020, 8:10.1136\/jitc-2019-000261","journal-title":"J Immunother Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013757","article-title":"Immune checkpoint inhibitor myocarditis: pathophysiological characteristics, diagnosis, and treatment","volume":"9","author":"Palaskas N","year":"2020","unstructured":"Palaskas N, Lopez-Mattei J, Durand JB, et al.. Immune checkpoint inhibitor myocarditis: pathophysiological characteristics, diagnosis, and treatment. J Am Heart Assoc. 2020, 9:e013757. 10.1161\/JAHA.119.013757","journal-title":"J Am Heart Assoc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf192","article-title":"2025 ESC Guidelines for the management of myocarditis and pericarditis","volume":"54","author":"Schulz-Menger J","year":"2025","unstructured":"Schulz-Menger J, Collini V, Gr\u00f6schel J, et al.. 2025 ESC Guidelines for the management of myocarditis and pericarditis. Eur Heart J. 2025, 54:55. 10.1093\/eurheartj\/ehaf192","journal-title":"Eur Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/403375-immune-checkpoint-inhibitor-induced-subacute-myocarditis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T11:06:04Z","timestamp":1756811164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/403375-immune-checkpoint-inhibitor-induced-subacute-myocarditis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.91464","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,2]]}}}